NEW YORK (Reuters Health) – Random blood glucose (RBG) measurements early in pregnancy can identify women with overt diabetes in pregnancy (ODIP), researchers from UK report in the…
NEW YORK (Reuters Health) – A Danish study indicates that among patients undergoing percutaneous coronary intervention, the use of zotarolimus-eluting stents (ZESs) rather than sirolimus-eluting stents (SESs) is…
NEW YORK (Reuters Health) – The high risk of fractures in the first year after solid organ transplantation can be roughly halved with bisphosphonate or vitamin D treatment,…
NEW YORK (Reuters Health) – Vitamin D, especially in combination with calcium, may reduce the risk of falls, according to a report in the July 27th online issue…
NEW YORK (Reuters Health) – The presence of peripheral neuropathy, and not diabetes per se, increases the risk of surgical site infections after foot and ankle surgery, according…
NEW YORK (Reuters Health) – Intensive treatment of type 2 diabetes that’s detected early through screening does not seem to reduce rates of subsequent complications, a Danish study…
NEW YORK (Reuters Health) – Mitotane combined with fast-acting steroidogenesis inhibitors might avoid the need for emergency bilateral adrenalectomy in patients with severe hypercortisolism, French researchers report in…
NEW YORK (Reuters Health) – Most patients with differentiated thyroid cancer metastasized to bone benefit from iodine-131 therapy, with stabilization of disease and significant reduction in pain, a…
NEW YORK (Reuters Health) – A novel glucose-lowering drug, dapagliflozin, improves glycemic control in patients with type 2 diabetes already on metformin, and it promotes significant weight loss,…
NEW YORK (Reuters Health) – A 4-year placebo-controlled trial of alpha-lipoic acid to treat diabetes-related polyneuropathy produced no improvement in the study’s composite endpoint, but there were clinically…